Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery [NA]
This document announces the completion of a prospective clinical study assessing the safety and efficacy of the Versius transoral robotic sy…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
A completed clinical trial evaluated exosome testing as a screening modality for HPV-positive oropharyngeal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating durvalumab with or without metformin in head and neck squamous cell carcinoma, including oral cavity…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer [EARLY_Phase 1]
Phase 1 trial evaluating durvalumab given before surgery in patients with oral cavity and/or oropharyngeal squamous cell carcinoma; the stud…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer [EARLY_Phase 1]
Early-phase trial evaluating Tolinapant in combination with radiation for cisplatin-ineligible, previously untreated locally advanced head a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin [Phase 1]
Phase 1 trial evaluating the safety and tolerability of Onalespib in combination with radiation therapy and cisplatin for locoregionally adv…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Improving Detection and Early Action for HPV-positive Oropharynx Cancer [NA]
Completed clinical trial evaluating methods for improved detection and early action in HPV-positive oropharyngeal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer [Phase 2]
Phase 2 trial evaluating de-escalated adjuvant radiation with adjuvant nivolumab in intermediate-high risk HPV-positive oropharyngeal squamo…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer [Phase 2]
Phase 2 trial evaluating the combination of pembrolizumab and cabozantinib in head and neck squamous cell carcinoma reported results, with r…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports the completion of a study evaluating image-guided proton therapy for locally advanced unresectable head an…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Ex Vivo 3D-ultrasound for Oropharyngeal Cancer [NA]
A completed clinical trial evaluating ex vivo 3D-ultrasound for oropharyngeal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating sintilimab in combination with carboplatin and nab-paclitaxel for resectable oral cavity and oropharyng…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer [Phase 1]
Phase 1 trial of nab-paclitaxel (albumin-bound paclitaxel) with carboplatin followed by chemoradiation in patients with recurrent head and n…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin [Phase 2]
Phase 2 trial evaluating sodium thiosulfate to prevent cisplatin-induced ototoxicity in patients with head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) [NA]
This update reports the completion of the Sinai Robotic Surgery Trial (SIRS) in HPV-positive oropharyngeal squamous cell carcinoma and notes…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC [Phase 2]
A Phase 2 clinical trial evaluating P53 mutational status and circulating cell-free HPV DNA as biomarkers to guide management of HPV-associa…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer [Phase 2]
Phase 2 trial update for alpelisib in participants with transorally resectable HPV-associated stage I-IVA oropharyngeal squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery [Phase 2]
A phase 2 trial evaluated the combination of nivolumab with carboplatin and paclitaxel in patients with stage III-IV head and neck squamous …
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy [Phase 2]
Phase 2 clinical trial update evaluating swallowing outcomes and circulating tumor DNA in HPV-related oropharyngeal cancer treated with tran…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating ficlatuzumab with or without cetuximab in cetuximab-resistant recurrent or metastatic head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment [Phase 2]
Phase 2 clinical trial update for ACTOplus Met XR in patients with stage I-IV oral cavity or oropharyngeal cancer undergoing definitive trea…
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer. [Phase 2]
Phase 2 clinical trial comparing adaptive dose painting by numbers with standard radiotherapy for head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: OPSCC N0 Nodal Control With Reduced IMRT [NA]
Clinical trial update for OPSCC with reduced IMRT in HPV-associated disease; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer [Phase 3]
Phase 3 trial evaluating reduced-dose radiotherapy for HPV-positive oropharyngeal cancer has posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck [Phase 2]
This Phase 2 trial evaluated chemotherapy with or without erlotinib in patients with metastatic or recurrent head and neck squamous cell car…